The healthcare sector is trading higher, led by significant stock price increases in medical device and clinical research companies following strong quarterly earnings reports. Notably, NovoCure (NVCR) and Medpace Holdings (MEDP) both announced second-quarter results that beat expectations and provided optimistic forward guidance, boosting investor confidence. Additionally, positive sentiment surrounds Cigna (CI) after the company announced an expansion of its AI-driven personalized care programs, which are projected to reduce medical costs. This contrasts with the broader market, which is trading cautiously lower.